Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Two Sigma Investments LP

Two Sigma Investments LP lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 153.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 219,839 shares of the company's stock after purchasing an additional 133,239 shares during the quarter. Two Sigma Investments LP owned about 0.18% of Privia Health Group worth $4,298,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Teza Capital Management LLC grew its position in Privia Health Group by 6.1% during the fourth quarter. Teza Capital Management LLC now owns 30,884 shares of the company's stock valued at $604,000 after purchasing an additional 1,777 shares in the last quarter. State of Wyoming boosted its position in shares of Privia Health Group by 125.0% in the fourth quarter. State of Wyoming now owns 18,227 shares of the company's stock valued at $356,000 after acquiring an additional 10,126 shares during the period. ProShare Advisors LLC lifted its stake in shares of Privia Health Group by 44.5% in the fourth quarter. ProShare Advisors LLC now owns 30,770 shares of the company's stock valued at $602,000 after buying an additional 9,475 shares during the period. Nuveen Asset Management LLC boosted its stake in Privia Health Group by 19.8% during the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after buying an additional 246,393 shares in the last quarter. Finally, Occudo Quantitative Strategies LP acquired a new stake in shares of Privia Health Group during the 4th quarter valued at about $207,000. 94.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PRVA. Needham & Company LLC restated a "buy" rating and set a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. Barclays raised their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday. Robert W. Baird raised their price objective on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Canaccord Genuity Group raised their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $27.77.

Insider Buying and Selling at Privia Health Group

In related news, CEO Parth Mehrotra sold 15,100 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the transaction, the chief executive officer now directly owns 454,281 shares in the company, valued at $10,598,375.73. The trade was a 3.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This trade represents a 3.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,579 shares of company stock valued at $1,226,367. 10.70% of the stock is currently owned by insiders.

Privia Health Group Price Performance

Shares of PRVA traded up $0.31 during mid-day trading on Friday, reaching $22.86. 1,260,625 shares of the company's stock traded hands, compared to its average volume of 739,124. The stock's 50-day moving average is $23.34 and its two-hundred day moving average is $22.72. Privia Health Group, Inc. has a 12 month low of $16.37 and a 12 month high of $26.09. The stock has a market cap of $2.79 billion, a P/E ratio of 228.62, a P/E/G ratio of 3.47 and a beta of 0.87.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.